Meeting
2016 ASCO Annual Meeting
Idiotype network induced by anti-GD2 immunotherapy is associated with long-term survival in patients with neuroblastoma.
Authors
Maya Suzuki
Memorial Sloan Kettering Cancer Center, New York, NY
Maya Suzuki , Irene Y. Cheung , Nai-Kong V. Cheung
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Pediatric Oncology
Track
Pediatric Oncology
Sub Track
Pediatric Solid Tumors
Citation
J Clin Oncol 34, 2016 (suppl; abstr 10570)
DOI
10.1200/JCO.2016.34.15_suppl.10570
Abstract #
10570
Poster Bd #
261
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Matched external control analysis of event-free survival (EFS) in patients with high-risk neuroblastoma (HRNB) receiving eflornithine (DFMO) maintenance.
First Author: Javier E. Oesterheld
Poster
2015 ASCO Annual Meeting
Immunological long-term follow-up of neuroblastoma stage IV patients after anti-GD2 CH14.18 antibody treatment.
First Author: Simone Kayser
Poster
2022 ASCO Annual Meeting
Clinical and biological features prognostic of survival after relapse of INRGSS-stage MS pattern neuroblastoma: A report from the International Neuroblastoma Risk Group (INRG) project.
First Author: Kevin M. Campbell
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Unraveling the oligometastatic phenotype and its association with pancreatic cancer survival.
First Author: John D Karalis